1Brandel JP. Clinical aspects of human spongiform encephalopathies,with the exception of iatrogenic forms [ J ]. Biomed pharmacother,1999,53(1) :14-18.
2Zivkovic S, Boada M, Lopez O. Review of Creutzfeldt-Jakob disease and other prion disease[ J]. Rev Neurol,2000, (12): 1171.
3Poser S,Zerr I, Schroeter A, et al. Clinical and diffrential diagnosis of Creutzfeldt-Jakob disease[J]. Arch Virol Suppl,2000, (16):153-159
4Blennow K, Lind B, Andersson E, et al. CSF-analysis in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practise [ J ]. Lakartidningen, 2001,98( 20 ): 2446-2451.
5Saiz A, Nos C, Yague J, et al. The impact of the introduction of the 14-3-3 protein asay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia. Catalan Collaborative Study Group for CJD[J]. J Neurol,2001 ,248(7) :592-594.
6Beaudry P,Cohen P,Brandel JP, et al. 14-3-3 protein,neuron-specific enolase,and S-100 protein in CSF of patients with CJD[J].Dement Geriatr Cogn Disord, 1999,10 ( 1 ) :40-46.
7Saiz A, Marin C, Tolosa E, et al. Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in CJD [ J ].Neurologia, 1998,13 (7)324-328.
8Zerr I, Bodemer M ,Gefeller O, et al. Detection of 14-3-3 protein in the CSF supports the diagnosis of CJD[ J]. Neurology, 1997,49(2) :593-595.
9Kenney K,Brechtel C,Takahashi H, et al. An enzyme -linked immunosorbent assay to quantify 14-3-3 protein in the CSF of suspected CJD patients[ J]. Ann Neurol, 2000,48 (3) :395-398.
10Collins S,Boyd A,Fletcher A, et al. Creutzfeldt-Jakob disease:diagnosis utility of 14-3-3 protein immunodetection in CSF[ J]. J Clin Neurosci ,2000,7 ( 3 ) :203-208.
8Prusiner SB. Prions. Proc Natl Acad Sci U S A,1998,95(23) : 13363-13383.
9Kretzschmar HA, Ironside JW, DeArmond S J, et al. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol, 1996, 53(9) :913-920.
10Zerr I, Bodemer M, Otto M, et al. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet, 1996,348 ( 9031 ) : 846 -849.
